Aptorum Group LTD 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NASDAQ
Niki BioSolutions, Inc. announced it has regained compliance with Nasdaq's minimum bid price requirement, closing at $1.00 or greater for ten consecutive business days.
NASDAQ
Niki BioSolutions, Inc. (formerly Aptorum Group Limited) and DiamiR Biosciences Corp. have completed their merger, establishing a new entity focused on biopharmaceutical and diagnostics.